Zhang Geng, Qin Weijun, Yuan Jianlin, Ming Changsheng, Yue Shuqiang, Liu Zhengcai, Yu Lei, Yu Ming, Gao Xiaokang, Zhou Yu, Wang Longxin, Yang Xiaojian, Dou Kefeng, Wang He
Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Med (Lausanne). 2020 Apr 28;7:148. doi: 10.3389/fmed.2020.00148. eCollection 2020.
To investigate the long-term effect of triple organ transplantation (liver, kidney, and pancreas) in a patient with end-stage liver disease, post chronic hepatitis B, cirrhosis, chronic renal failure, and insulin-dependent diabetes mellitus caused by chronic pancreatitis and to explore the optimal surgical procedure. A 43-year-old man with progressive emaciation and hypourocrinia for 2 months. Results indicated exocrine pancreatic insufficiency and insulin-dependent diabetes related to chronic pancreatitis (CP) after developing end-stage hepatic and renal failure. Simultaneous piggyback orthotopic liver and heterotopic pancreas-duodenum and renal transplantation was performed in 2005. Pancreatic exocrine secretions were drained enterically to the jejunum, and the donor kidney was placed in the left iliac fossa. Patient was prescribed with prednisone, tacrolimus, mycophenolate mofetil, Rabbit Anti-human Thymocyte Immunoglobulin, and simulect for immunosuppression. Satisfactory hepatic and pancreatic functional recovery was achieved within 7 days post-surgery. The kidney was not functional, and continuous renal replacement therapy was used. However, the donor kidney was removed at day 16 post-surgery due to acute rejection reaction. A new renal transplantation at the same position was performed, and satisfactory kidney function from the new graft was achieved 3 days later. In 14 years of follow-up, patient has not had any rejection reactions or other complications such as pancreatitis, thrombosis, and localized infections. The patient is insulin independent with normal liver and renal functions. FK506+Pred was used for immunosuppression, and the tac tough level maintained 3.0-4.5 ng/ml. Lamivudine was prescribed for long-term use to inhibit HBV virus duplication. Simultaneous piggyback orthotopic liver and heterotopic pancreas-duodenum and renal transplantation is a good therapeutic option for patients with exocrine pancreatic insufficiency and insulin-dependent diabetes combined with hepatic and renal failure.
为研究同期肝、肾、胰联合移植对一名终末期肝病患者(该患者既往有慢性乙型肝炎、肝硬化、慢性肾衰竭,以及由慢性胰腺炎导致的胰岛素依赖型糖尿病)的长期影响,并探索最佳手术方式。一名43岁男性,出现进行性消瘦和少尿2个月。结果显示,在发生终末期肝、肾衰竭后,出现了与慢性胰腺炎(CP)相关的外分泌性胰腺功能不全和胰岛素依赖型糖尿病。2005年进行了背驮式原位肝移植、异位胰十二指肠移植和肾移植。胰腺外分泌液经肠道引流至空肠,供肾置于左髂窝。给予患者泼尼松、他克莫司、霉酚酸酯、兔抗人胸腺细胞免疫球蛋白和舒莱进行免疫抑制治疗。术后7天内肝脏和胰腺功能恢复良好。移植肾无功能,采用持续肾脏替代治疗。然而,术后第16天因急性排斥反应切除了供肾。在同一位置进行了再次肾移植,3天后新移植肾肾功能良好。在14年的随访中,患者未发生任何排斥反应或胰腺炎、血栓形成及局部感染等其他并发症。患者不再依赖胰岛素,肝肾功能正常。采用FK506+Pred进行免疫抑制,他克莫司血药浓度维持在3.0 - 4.5 ng/ml。长期服用拉米夫定抑制乙肝病毒复制。同期背驮式原位肝移植、异位胰十二指肠移植和肾移植是治疗外分泌性胰腺功能不全和胰岛素依赖型糖尿病合并肝、肾衰竭患者的良好选择。